The Atomic Medicine Initiative
Focus
Cancer
Analytical chemistry
Diagnostics
Group leader
Philip Doble
The Atomic Medicine Initiative brings together leading university and medical researchers who believe that meaningful outcomes begin with an inventive concept driven by technology and small groups of dedicated scientists which creates a ripple. When its importance is recognised, the ripple becomes a series of large waves comprised of national and international networks.
Our laboratories are equipped with state of the art analytical and medical technologies housed at multiple locations at the University of Technology Sydney, The Howard Florey Institute, The Doherty Institute, and St. George and St Vincents Hospitals. The technologies pursue areas of research to improve medical treatments and diagnostics of cancer, bacterial infections, based on measuring metals, and their roles in the pathogenesis of disease.
Our research involves the development of cancer diagnostics and therapeutics; investigation of metals and infections for the development of much needed new antibiotics; metals that modulate memory associated with ageing and neurodegenerative disorders, machine learning for the identification of tumours to improve interpretation of histopathological stainings; and development of quantitative methods for diagnosis and monitoring of Duchenne’s muscular dystrophy.
